Evidence suggests that providers are not adhering to current testosterone replacement
therapy guidelines when treating male hypogonadism. Understanding the diagnosis and …

Objective Men with male hypogonadism (MH) experience sexual dysfunction, which
improves with testosterone replacement therapy (TRT). However, randomised controlled …

A dichotomic distinction between “organic” and “functional” hypogonadism is emerging. The
former is an irreversible condition due to congenital or “acquired”“organic” damage of the …

Introduction: Since the phenotype and clinical need of the hypogonadal individuals changes
dramatically over time, versatile therapies are needed. Areas covered: The authors review …

Introduction: The aim of the present study was to evaluate, with this retrospective study, the
patients with hypogonadotropic hypogonadism, who were followed up in our clinic in the last …

Summary The Hypogonadism in Males study estimated the prevalence of hypogonadism
[total testosterone (TT)< 300 ng/dl] in men aged≥ 45 years visiting primary care practices in …

It has been estimated that hypogonadism currently affects up to 4 million American men, and
as the population ages, this number will only rise. Nevertheless, only 5% of these men are …

Over the years, clinicians have proposed various therapeutic agents to treat male infertility.
These agents are intended to improve male reproductive impairment either by addressing a …

Hypogonadism is a condition defined by an abnormal decrease in the functional capability
of the gonads, resulting in the delay of growth and sexual development. The two main …

Context The present summary of the European Association of Urology (EAU) guidelines is
based on the latest guidelines on male sexual health published in March 2021, with a last …